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Abstract
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Background—Acute kidney injury (AKI) occurs in one in four children admitted to the intensive
care unit (ICU) and AKI severity is independently associated with increased patient morbidity and
mortality. Early prediction of AKI has the potential to improve outcomes. In smaller, single center
populations, we have previously derived and validated the performance of the renal angina index
(RAI), a context driven risk stratification system, to predict severe AKI.
Methods—A prospective, observational study (AWARE1, January–December 2014) was
conducted in intensive care units from 32 centers in 9 countries. The primary outcome was the
presence of severe AKI (“AKIS”; Stage 2–3 AKI KDIGO guidelines) on the third day after ICU
admission (). We compared the performance of the RAI to changes in serum creatinine relative to
baseline (SCr/Base) for prediction of the primary outcome and secondary outcomes of interest. A
RAI ≥ 8 defined fulfillment of renal angina (RA+); RA+ was compared to SCr increased relative
to baseline (“SCr>Base”; using maximum SCr in first 12 hours of ICU admission).
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Findings—The 1590 patients studied were 55% male and had median age of 54.5 months. 286
patients (17.9%) were RA+. AKIS occurred in 121 (42.3%) RA+ vs. 247 (18.9%) RA-patients
(relative risk (RR) 2.23; 95% confidence interval (CI): 1.87–2.66, p<0.001). 368 (23.1%) patients
with AKIS had increased renal replacement therapy utilization (10.9% vs. 1.5%, p<0.001) and
increased mortality (7.6% vs. 4.3%, p=0.01) compared to patients without AKIS. RA+
demonstrated better prediction for AKIS than SCr>Base (RR: 1.61; (1.33–1.93), p<0.001) which
was maintained on multivariate regression (independent odds ratio (OR): RA+ 3.21; 95% CI
(2.20–4.67) vs. SCr>Base 0.68; 95% CI (0.49–4.94)).
Interpretation—Earlier, better prediction of severe AKI has the potential to improve AKI
associated patient outcomes. Compared to isolated, context-free changes in SCr, renal angina risk
assessment improved accuracy for prediction of severe AKI in critically ill children and young
adults.
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Introduction
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Acute kidney injury (AKI) occurs frequently in critically ill patients and is associated with
poor patient outcome. In both adults and children, increasing AKI severity is independently
associated with incremental increases in mortality.1, 2 Current management guidelines for
patients with AKI recommend augmentation of supportive care and are intended to limit
AKI progression3 and recent reports suggest that early recognition of AKI risk can expedite
both incorporation of the guidelines in critically ill patients and early employment of
prevention strategies to reduce AKI severity.4-6 This current state of AKI management is
implicitly reactive and employs strategies based on mitigation of established AKI. A
proactive approach aimed at prevention of injury, requires the ability to reliably identify
patients at-risk for AKI, or those with developing AKI early in their course.7,8 A broader
appreciation and recognition of AKI risk factors is a cornerstone of international directives
to reduce the global AKI burden.8,9

Author Manuscript

Adjudication of patient risk modulates decision making and management strategy. A clear
example is the difference in management of fever in a previously healthy child versus in an
immunocompromised child with an indwelling central venous catheter. Management of
critically ill patients is also dependent on risk assessment. International consensus guidelines
account for patient risk factors to guide corticosteroid therapy and multiple antimicrobial
agents in treatment of severe sepsis.10-12 The time-dependent treatment algorithms for
ischemic stroke are guided by both physical symptoms and risk factors. Recent evidence
suggests the time to initial benzodiazepine administration to abort seizures should vary
based on the presence or absence of a history of epilepsy syndrome with prior status
epilepticus. Management of acute chest pain varies by the presence or absence of the
Framingham risk factors for atherosclerotic heart disease. In each of these examples, patient
context and risk is incorporated into the decision-making process for patient management.
Ultimately, improved patient outcome occurs because of risk stratified patient management.
Risk stratification for AKI may be possible using the concept of renal angina,14 which
combines risk factors and early signs of loss of function (increases in serum creatinine or
degrees of fluid accumulation) to stratify patients for risk subsequent severe AKI (Stage 2 or
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3 AKI by the KDIGO criteria3) (Figure 1, Supplement 1).7,15,16 We previously derived and
validated a simple mathematical operationalization of renal angina, the renal angina index
(RAI), in multiple relatively small, single-center pediatric populations. The predictive
efficacy of the RAI for development of severe AKI three days after admission to the
intensive care unit (ICU) was tested.17-19 The time point of three days was chosen because
of the poor patient outcome associated with severe AKI occurring 48 hours after ICU
admission and as a point to signify clinically significant AKI (termed “persistent AKI”).20
The RAI was highly sensitive as a screening tool for severe AKI risk; absence of renal
angina, defined as an index value below the validated cut-off of 8, demonstrated high
negative predictive (92–99%) value for severe AKI on day three. Furthermore, confirmatory
biomarkers integrated into the RAI of patients with a RAI ≥ 8 improved positive prediction
for AKI (i.e., higher pre-test probability increasing post-test probability).19

Author Manuscript

We now present results from a large prospective, multi-national study of children assessing
the ability of the RAI to predict development of severe AKI. This work expands our
preliminary study findings and tests the RAI in a larger and more heterogeneous population
of patients admitted to pediatric ICUs across the world. We hypothesized that compared to
isolated, context-free elevation in serum creatinine (SCr), application of the RAI would
increase the predictive accuracy for severe AKI.

Methods
Study Design and Ethics

Author Manuscript

We conducted the “Assessment of Worldwide AKI, Renal Angina and Epidemiology
(AWARE)” study (NCT01987921) and have published the design21 and the initial
epidemiologic results.1 Briefly, AWARE was a prospective observational study that recruited
children and young adults from 32 pediatric ICUs across Asia, Australia, Europe, and North
America (Supplement 2). Each center collected data for three consecutive months in 2014.
All patients between three months and 25 years admitted to ICU ≥48 hours were eligible.
Exclusion criteria were: a) history of stage 5 chronic kidney disease (i.e., estimated
glomerular filtration rate (eGFR) < 15 ml/min/1.73m2 or on maintenance dialysis) and b)
kidney transplantation in the preceding 90 days.
Eligible patients’ medical records were reviewed to collect data on the following timelines:
up to three months before (SCr only), daily during the first 7 days and on day 28 after ICU
admission. Day 28 outcome data were recorded whether the patient was still in ICU,
discharged, or dead. All centers obtained health research ethics board approval prior to
commencement with approval for a waiver of informed consent.

Author Manuscript

Metrics
Baseline SCr (Base) was defined as the lowest SCr in the 3 months prior to admission. When
baseline SCr was unavailable, a baseline SCr was imputed by calculating a body surface area
(m2) using patient’s height and weight and an estimated glomerular filtration (eGFR) of 120
ml/min/1.73m2, as validated in the literature. For this analysis, we implemented the Kidney
Disease Improving Global Outcomes (KDIGO) staging criteria to define and classify AKI;
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however, renal replacement therapy (RRT) utilization was assessed as an outcome and not
counted as Stage 3 AKI. We required measurement of ≥1 SCr or ≥12 hours of recorded UOP
in the first seven days of admission to assess for AKI. Severe AKI (denoted “AKIS”) was
defined as ≥ Stage 2 AKI as these stages are associated with worse outcomes in children.
The worse AKI stage defined by the serum creatinine or UOP criteria (both data required for
patient inclusion) was used to classify AKI stage. When explicitly specified, all-stage AKI
(KDIGO stages 1–3) was also analyzed (“AKIa”). The RAI score was determined after 8–12
hours on the day of admission as previously described combining risk and injury scores
(Figure 1).18 Determination of the “injury” component of the RAI utilized the worse of
either percent fluid overload (% FO) from ICU admission or change of SCr from baseline
(SCr/Base). The change from baseline was used to determine the binary definition of
SCr>Base or SCr≤Base. For both RAI and SCr/Base determination, the maximum SCr
measured between ICU admission and hour 12 on admission day was used. A RAI ≥ 8 was
considered fulfillment of renal angina based on our previous derivation and validation
studies (Supplement 1). Fulfillment or absence of renal angina was denoted “RA+” or “RA
−”, respectively. Any elevation of Dayo-SCr over baseline was denoted as “SCr>Base”.

Author Manuscript

Outcomes
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The primary outcome of interest was the presence of AKIS on ICU Day3 (AKIS). Patients
with AKIS before Day3 or after Day3 were not included as positive for AKIS. The primary
analyses tested the diagnostic utility of the RAI for the prediction of this outcome compared
to SCr/Base. The primary outcome was chosen for multiple reasons. Our prior data and the
data presented in this report verify the association between Day3-AKIS and poor patient
outcomes. Additionally, this point in ICU course has been suggested by international
consensus as beyond the point of rapid reversal of transient AKI.20 In fact, AKI prior to this
point, as suggested by the consensus, should no longer be termed severe AKI. Secondary
outcomes of interest included presence of all-stage AKI on Day3 (AKIA) and longer term
outcomes assessed at 28 days: use of renal replacement therapy (RRT), duration of
mechanical ventilation (days), ICU length of stay (LOS), and mortality.
Statistical Analyses
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Continuous variables are reported as median with interquartile range and compared using the
Mann-Whitney test. Categorical variables are summarized using frequency and proportion
and compared by chi-square or Fisher’s exact tests. A RAI cutoff of ≥ 8 was used to define
renal angina fulfillment [RA (+)] and this cut-off was used for diagnostic test evaluations.
For tests of comparison, RAI was compared to SCr/Base. RA+ was compared to SCr>Base.
Bivariate and multivariate logistic models were used to correct for significant covariate
effects and identify independent associations with outcomes. All bivariate associations
carrying associations with p<0.15 were included as multivariate model terms. Association
between severity of illness (SOI) score and outcomes were only performed as bivariate
analyses as the linearity of these scores cannot be assumed. PRISM-III – Pediatric Risk of
Mortality Score III, PIM-2: Pediatric Index of Mortality-2, and PELOD: Pediatric Logistic
Organ Dysfunction score were used based on center preference.16 Multivariate regression
was also performed including both RA+ and SCr>Base as model terms to delineate the
independent association with chosen outcomes for each predictor. Statistical analyses were
Lancet Child Adolesc Health. Author manuscript; available in PMC 2019 February 01.
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performed using SigmaStat version 13.1 software (San Antonio, Texas). A p-value of <0.05
was considered significant.
Role of the Funding Source—This work was supported by a grant (NIH P50
DK096418, to Drs. Basu and Goldstein) from the Pediatric Nephrology center of Excellence
at Cincinnati Children’s Hospital Medical Center. Dr. Kaddourah’s Pediatric Acute Care
Nephrology and Dialysis Fellowship at Cincinnati Children’s Hospital Medical Center was
supported by an educational grant from Gambro Renal Products.
The funding source had no role in study design, collection of data or data analysis, data
interpretation, or writing of the report. All primary authors (RKB, AK, SLB) had full access
to all of the data. The corresponding author (RKB) had the final responsibility to submit for
publication.
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Results
Patients
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5237 children and young adults were eligible in AWARE; in the 4683 patients with both
Day28 and maximum AKI stage data available, 543 (11.6%) developed AKIS within the first
7 days.1 For this analysis, we studied the cohort of patients still admitted to ICU on Day3
(n=1590) (Figure 2). All patients had complete data for Days 0, 3, and 28. The current study
cohort was sicker than the overall eligible patient population (5237), the 4683 patients
reported in the primary epidemiological survey, and the population in AWARE not studied in
this cohort (Supplement 2), as evidenced by higher severity of illness scores and increased
morbidities such as use of extracorporeal therapy and renal replacement therapy (RRT).
Mortality rates were higher in the study population studied than the remaining cohort from
the reported AWARE dataset (5.1% vs. 2.6%, p<0.001).
RA+ occurred in 286/1590 (17.9%) of patients. Compared to RA−, RA+ was associated
with a higher incidence of diagnoses such as shock and cardiovascular illness and were less
commonly diagnosed with trauma or central nervous system illness (Table 1). Additionally,
RA+ was associated with both a greater risk of both AKIS (RR: 2.23; 95% CI 1.87–266, p <
0.001) and AKIA (RR: 1.87; 95% CI 1.65–2.14 p<0.001). RA+ was associated with worse
outcomes including: increased utilization of renal replacement therapy (12.6% vs. 1.7%,
p<0.001), prolonged duration of mechanical ventilation (median (IQR) 4 (0,9) vs. 0 (0,5) in
days, p<0.001), and increased mortality (11.2% vs. 3.8%, p<0.001).
Primary Outcome

Author Manuscript

368/1590 (23.1%) patients developed AKIS. Patients with AKIS were older than patients
without AKIS (p=0.002). Severity of illness scores trended toward patients with AKIS being
sicker but did not demonstrate a consistently significant difference (Table 2). AKIS was
associated with increased utilization of renal replacement therapy (p<0.001) and increased
mortality (7.6% vs. 4.3%, p<0.01) (Table 2). RA+ demonstrated an increased relative risk
for AKIS compared to SCr>Base (RR 1.61; 95% CI: 1.33–1.93, p<0.001) (Table 3), despite
the lack of differences in severity of illness or age between these cohorts. A side-by-side
comparison of multivariable regression demonstrated the persistence of the independent
Lancet Child Adolesc Health. Author manuscript; available in PMC 2019 February 01.
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association between RA+ and AKIS after adjustment for all significant model terms from
bivariate analyses. The independent association of SCr>Base for this outcome did not persist
in this modeling (Table 4). Further, multivariable regression including both RA+ and
SCr>Base as model terms also demonstrated a persistent independent association of RA+
with AKIS while a loss of independent association between SCr>Base and AKIS.
RA+ and SCr>Base demonstrated similar discrimination for AKIS (area under curvereceiver operating characteristics of 0.83 (95% CI; 0.79–0.86) versus 0.86 (95% CI; 0.82–
0.89), respectively (p=ns)). However, the predictive accuracy for AKIS of RA+ was superior
to SCr>Base: specificity (87% vs 70%), positive predictive value (31% vs. 25%), and
positive likelihood ratio of RA+ (5.0 vs. 2.6) (Table 3).
Secondary Outcomes

Author Manuscript

RA+ and SCr>Base were both more common in patients with worse outcome (RRT
utilization and mortality) (Supplements 3–4). For both RRT and 28-day mortality, RA+
carried an increased relative risk of outcome compared to SCr>Base for RRT utilization
(2.14 (1.39–3.28), p<0.001) and mortality (1.77 (1.15–2.74), p=0.009). Similar to the
primary outcome, multivariable regression analyses including both RA+ and SCr>Base as
significant bivariate model terms demonstrated a persistent independent association of RA+
with RRT utilization and mortality with a concomitant loss of association between
SCr>Base and these outcomes (Table 5).
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An analysis of the accuracy of identification of AKI stage on Day3 patients was performed
(Supplements 5–7). 171 patients (108%) with AKIS were negative for both RA+ and Day0SCr>Base and conversely, 142 (8.9%) patients were positive for both on admission but
negative for AKIS (Supplement 6). Despite being a smaller proportion of the studied cohort
(17.9% vs. 43.8%), patients with RA+ were more likely to suffer AKIS than any patient with
SCr>Base (121 (42.3%) vs. 184 (26.4%), respectively (p<0.001) (Supplement 7).

Discussion

Author Manuscript

The multi-national, multi-center AWARE and AKI-EPI epidemiologic studies describe
strong associations between severe AKI and worse patient outcome in adults and children.1,2
Opportunities to improve predictive precision and accuracy for significant severe AKI can
assist clinicians managing patients on the front-line, early in the ICU course. In this large,
multi-center prospective observational study in critically ill children and young adults, we
demonstrate assessment of renal angina, using the RAI risk stratification system early in
ICU course, confers a distinct predictive advantage compared to serum creatinine increase
for clinically significant AKI. Comparison of the test characteristics illustrates the basis of
the important predictive improvement conferred by renal angina. Renal angina fulfillment
improves the specificity (by ~ 20%) and likelihood (two-fold, with non-overlapping
confidence intervals) for Day3-AKIS than context-free increases in creatinine. These
improvements indicate an increase in the posttest probability for disease.
We confirm and broaden the findings of our previous single-center studies reporting the
performance of the RAI for severe AKI prediction. This study is, however, distinct from our

Lancet Child Adolesc Health. Author manuscript; available in PMC 2019 February 01.

Basu et al.

Page 7

Author Manuscript

previous work. None of our previous studies compared the performance of the RAI to
increases in creatinine concentrations. Most of our previous reports were retrospective
analyses.17,18 The inclusion criteria for expected length of stay were less stringent between
our prospective pilot study AKI-CHERUB (NCT01735162) and the AWARE study (72
hours vs. 48 hours) resulting in more patients included in AWARE with a lower severity of
illness (assessed by severity of illness score comparisons). The inclusion of more patients
and patients from a wider range of illness severity (i.e., inclusion of “less” sick patients),
increases the generalizability and validity of our findings. Additionally, the previous work
was primarily performed at only two institutions while the current study was performed at
32 separate, unique international institutions, which strengthens the validity of the model
and findings.

Author Manuscript
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Clinical context drives management of hospitalized patients. A clinician adjudicates patient
context to provide clinical decision support for both the optimal intervention and the urgency
of the intervention. For example, time to antibiotic therapy in the management of sepsis is
directly related to mortality23. Both timing and type of antimicrobial therapy are adjudicated
by patient risk in the 2016 Surviving Sepsis Guidelines. Risk assessment in a patient with
physical symptoms consistent with a stroke directs immediate management options (e.g.,
thrombolytic therapy). The most apt example for how risk adjudication modulates
management resulting in improved patient outcome is for acute coronary syndrome (ACS).
In ACS, the clinical context of risk factors for heart disease (Framingham) combined with
physical signs of coronary vasospasm (Prinzmetal’s Angina) increase the pre-test probability
of myocardial infarction. In this context, a clinician directs electrographic and confirmatory
biomarker testing, ultimately optimizing prediction and/or identification of a heart attack. In
the 1960s and 1970s, the adoption of this construct into clinical care provided a framework
for clinicians and researchers to discover new therapeutic options for a disease process with
high mortality. The construct continues to provide clinical decision support to this day and
thanks to coronary bypass surgery, thrombolytic therapy, and small vessel stenting, more
patients have an increased probability of survival.
The RAI may help differentiate reversible (functional) AKI from persistent (structural) AKI.
24 Compared to context free increases in SCr, the relative risk for severe AKI at Day 3 is
two-fold greater for patients fulfilling renal angina. Using creatinine alone, prediction of any
stage of AKI would be correct only 40% of the time and only 25% of the time for severe
AKI. By comparison, correct prediction by RAI occurs more frequently for any stage AKI
(60%) and for severe AKI (40%). RAI increases predictive success (accuracy) and reduces
predictive error (cost), with a potential increase in value.
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Early prediction of severe AKI may improve patient outcomes. The majority of therapeutic
trials to date have studied patients with established and severe AKI, enrolled well into ICU
course. Even though on admission they were no sicker compared to those without AKI,
patients with severe AKI three days after hospital admission had worse outcome by every
measure assessed. Taken together, this means the RAI may provide a way to study treatment
strategies earlier in the course of AKI25 Also, the RAI may enable targeted therapeutic trial
design based on degree of AKI risk.19 Finally, RAI-directed biomarker assessment should
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bolster positive predictive for AKI and refine targeted testing strategies (biomarker work and
analysis currently in process).
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Our study has several strengths and limitations. The large population and multinational size
studied is rare for any prospective pediatric study. The heterogeneity between units and
countries could have varied based on practice style. This is simultaneously a strength and a
weakness – it further supports the pragmatic nature of this study, but does not offer ready
conclusion on steps to take or follow to mitigate the problematic sequelae of AKI. The study
did not account for patient management differences amongst providers or between
institutions, nor did it place any a priori management protocols on patients in the ICU.
Again, as we did not change local practice, our findings are more generalizable. Future work
will study biomarkers and directed confirmatory testing (urine was collected in AWARE
from over 600 patients). A statistical limitation was that the model term of AKIS loses
independent association with mortality in multivariate analysis when renal angina fulfillment
is also included, presumably because of patients deceased by Day 3. Renal angina has
inherent strengths and weaknesses. The index calculation, based on existing pediatric
epidemiology and associated outcomes (Figure 1, Supplement 1)16 – relies upon metrics
used for early signs of injury known to be suboptimal for rapid response to injury. Even
though the positive predictive value was higher than SCr>Base, 57.7% RA+ patients were
negative for AKIS on Day 3. Additionally, 18.9% of patients were negative for RA yet
positive for AKIS on Day 3. The reasons for these predictive errors are multifactorial. A
limitation of the index itself is the reliance on increases in serum creatinine 12 hours into
ICU course. The rate of rise in creatinine in response to injury is a known limitation. Fidelity
of data entry by bedside staff relating to urine output or other laboratory indices can vary
depending on institution and integration of electronic medical record systems. Finally, we
admit application of RAI across patients with multifactorial disease and reliability of
creatinine as it relates to patient volume status,26 as well as other adjustments based on
patient population, will be required and will ultimately enhance refinement of the RAI. Still,
the RAI is easily calculable and quick (not reliant on sophisticated calculation or derivation
methods) and based on universally accessible, standard collected vitals and laboratory data
(even if imperfect).

Conclusions
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Fulfillment of renal angina is associated with the development of poor renal function and
overall poor outcome. The renal angina index is superior to context-free changes in
creatinine and gives a provider an early window to recognize the potential for severe AKI
that will occur at a meaningful time for a critically ill patient. Renal angina supplies the
context needed to increase the pre-test probability and accuracy of AKI prediction in
critically ill patients with a heterogeneous mix of AKI risk.

Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Research in Context
Evidence Before This Study

Author Manuscript

We searched PubMed and OViD databases between Jan 1 1997 and Oct 1 2017 for
studies in critically ill children and adults using the following individual or grouped
search terms: “risk stratification”, “acute kidney injury” (or “acute renal failure”),
“pediatric”, and “critical illness”. In available results, analysis of the references used per
source was conducted. Additionally, the expertise of the Prospective Pediatric AKI
(ppAKI: www.ppaki.org) was leveraged. Finally, this manuscript was the principal
analysis after the epidemiologic report of the AWARE Study Investigators (Assessment
of Worldwide Acute Kidney Injury, Renal Angina, and Epidemiology). The investigators
represent a global cross-section of acute care nephrology practitioners (nephrologists and
pediatric intensivists) providing expertise on relevant data sources and references related
to risk stratification and AKI. A majority of the 128 studies identified in our
comprehensive search were excluded from in-depth analysis as they were small case
reports or small size (< 50 patients), non-human, or not studied in critically ill patients.
Of the 29 reports examined closely, 17 were reviews or commentaries, 4 were our own
reports, and 9 were focused on different biomarker-based risk stratification assessments
(neutrophil gelatinase associated lipocalin, cell-cycle arrest markers, and the furosemide
stress test). The overriding conclusion was a paucity of an objective assessment system
based on risk factors for AKI, allowing a clinician to properly adjudicate a marker of
injury (creatinine or a novel biomarker). Many studies of the biomarkers or functional
tests identify good to excellent discrimination for prediction of AKI (area under curve
receiver operating characteristic > 0.80), but they are tested in single-center, extremely
sick populations.
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Added Value of this Study

Author Manuscript

The Assessment of Worldwide Acute Kidney Injury, Renal Angina and Epidemiology
(AWARE) study is the largest continuously collected prospective observational study of
critically ill children and young adults to date. Our multi-centre and multi-national
registry included patients of significant heterogeneity (past medical history and
comorbidities) and severity of illness. The study was designed with the express purpose
of being able to assess the renal angina index methodology – purposely collecting
specific data and at certain time points to expand our initial validation studies –
demonstrating that across a wide swath of patients, risk stratification and provision of
context to early signs of kidney injury is not only feasible and simple, but practical as
well. Our findings of the predictive advantage using the objective-data based renal angina
index fits squarely within the new consensus statements from the Acute Dialysis Quality
Initiative (ADQI) for the definition of “acute kidney injury” (injury determined after 48
hours).
Additionally, the data provide a methodology to direct confirmatory biomarker testing,
optimizing their use for prediction of severe AKI (the next step of our research).
Implications of all the Available Evidence
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Of primary importance is that this report again emphasizes the negative associations
between the presence of severe AKI and clinical outcomes in critically ill children and
adults. The significantly worse outcomes of patients suffering AKI at Day 3 after
admission highlights important opportunities: 1) prediction of Day 3 – AKI may be the
first step in mitigation of AKI severity, 2) Screening out those patients on Day 0 with
very low risk of Day 3 AKI can direct and target resources and potentially direct novel
therapeutics on the population of greatest benefit, and 3) leverage of the electronic
medical record – to provide support for decision making (i.e., the renal angina index can
be integrated into existing EMR systems) is the next step in getting ahead of the AKI
epidemic in children. Additional and next studies will leverage our existing data and also
continue to grow the AWARE investigator network (e.g., the recently published
AWAKEN – Assessment of Worldwide Acute Kidney Injury Epidemiology in Neonates
works together with AWARE). Together, our previous reports and this report will
continue building the foundation needed to attract the attention, resources, and personnel
needed to make progress and improve outcomes for children who suffer AKI.
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Figure 1. The Renal Angina Index

The index calculation for the fulfillment of renal angina is assessed 12 hours after a patient
is admitted to the intensive care unit and used for prediction of severe AKI 72 hours (3 days)
later. Risk factors are determined as described and assigned a point value (1, 3, and 5).
Mechanical ventilation and vasoactive support should be used within the 12-hour time point
but are not required to be simultaneously for a patient to be categorized as a “5”. Injury
strata are described and assigned to a patient as appropriate. The index is a multiplication of
the risk and injury scores assigned. SCr = serum creatinine/baseline = relationship to
baseline serum creatinine, %FO = % fluid overload as described previously.27
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Figure 2. CONSORT Diagram
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Inclusion in this analysis required full data on ICU Day 3 – inclusive of serum creatinine and
urine output measurements. All patients included from the original AWARE study
(1590/5237) had full data from the day of ICU admission, Day 3, and Day 28. Renal angina
was fulfilled (RA+) on the day of admission in 17.9% of the studied patients. These patients
were older and sicker and had worse outcome than patients without renal angina on
admission (RA−). Although no different by multiple markers of severity of illness, patients
with AKI on Day 3 (AKIS) were older and had worse outcome than patients without AKI. P
values for comparison are listed in Supplement 2: Current patients (1590) vs. AWARE
patients excluded for this study (3647), Table 1: Renal angina + vs. renal angina −, and Table
2: AKIS vs. No AKIS.
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Table 1

Author Manuscript

Renal Angina Fulfillment, Demographics and Outcomes
RA−
N=1304 (82.1)

RA+
N=286 (17.9)

P Value

Male

738 (56.6)

144 (50.3)

0.05

Age in months

89 (27,167)

94 (30–172)

0.36

0.88 (0.53, 1.42)

0.94 (0.54, 1.47)

0.22

337 (26.1)

135 (52.2)

<0.001

Variable

BSA m2
Diagnosis Group*
Shock
CV

75 (4.3)

20 (7.7)

0.003

619 (35.1)

129 (36.3)

0.38

Trauma

263(27.9)

64 (20.7)

0.001

CNS

288 (21.2)

39 (15.8)

0.008

Pain Management/Sedation

44 (3.7)

9(3.1)

0.56

History of Transplantation

55 (4.2)

57 (19.9)

<0.001

PRISM-3

5 (3,8)

7 (3, 14)

0.02

PIM-2

3 (1,4)

3 (1, 6)

0.16

11 (1, 12)

11 (1, 19)

0.011

No AKI

916 (70.3)

121 (42.3)

<0.001

Stage 1

141 (10.8)

44 (15.4)

0.03

Stage 2

53 (4.1)

41 (14.3)

<0.001

Stage 3

194 (14.9)

80 (28.0)

<0.001

All-stage AKI (AKIA)

388 (29.7)

165 (57.7)

<0.001

Severe AKI (AKIS)

247 (18.9)

121 (42.3)

<0.001

2.23 (1.87–2.66)

<0.001

4(0.1)

0 (0)

nc

ECMO*

14 (1.1)

9(3.1)

0.007

Renal Replacement Therapy*

22 (1.7)

36 (12.6)

<0.001

MV Duration

0 (0,5

4(0,9)

<0.001

ICU LOS

5 (3,8)

6 (3,10)

0.21

Mortality

49 (3.8)

32 (11.2)

<0.001

Respiratory

Author Manuscript

Severity of Illness Score

PELOD
Day 3 AKI Incidence

Author Manuscript

Relative Risk (AKIS)^
Ventricular Assist Device*

Author Manuscript

Categorical Variables expressed as n (% of cohort)
Continuous Variables expressed as medians with interquartile ranges
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*

More than one diagnosis group is possible

^

Z-statistic = 8.96

Author Manuscript

RA = renal angina (+ = positive, − = negative) BSA = body surface area, IQR = interquartile range, CV = cardiovascular, CNS = central nervous
system, PRISM-3 = Pediatric Risk of Mortality 3, PIM-2 =Pediatric Index of Mortality 2, PELOD = Pediatric Logistic Organ Dysfunction, KDIGO
– Kidney Diseases Improving Global Outcomes, AKI = acute kidney injury, ICU = intensive care unit, ECMO = extracorporeal membrane
oxygenation, MV = mechanical ventilation, LOS = length of stay
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Table 2

Author Manuscript

Day 3 AKI, Demographics and Outcomes
No AKIS
N=1222 (76.8)

AKIS
N=368 (23.1)

P Value

683 (55.9)

199 (54.1)

0.54

Age in months

49.1 (16.3, 127.9)

75.5 (17.9, 165.7)

0.002

BSA m2

0.67 (0.46, 1.18)

0.84 (0.47, 1.36)

0.005

343 (28.1)

129 (35.1)

0.01

70 (5.7)

29 (7.9)

0.13

Respiratory

581 (47.5)

167 (45.4)

0.47

Trauma

237 (19.4)

90 (24.5)

0.04

CNS

Variable
Male

Diagnosis Group*
Shock
CV

Author Manuscript

263 (21.5)

64 (17.4)

0.09

Pain Management or Sedation

41 (3.4)

12 (3.3)

0.93

History of Transplantation

62 (5.1)

50 (13.6)

<0.001

5 (3, 8)

7 (3, 12)

0.03

Severity of Illness Score
PRISM-3
PIM-2

3 (1, 4)

3 (1, 5)

0.09

PELOD

11 (1, 12)

11 (1, 12)

0.52

RA+

165 (13.5)

121 (32.9)

<0.001

No AKI

1040 (85.1)

248 (67.4)

<0.001

Stage 1

140 (11.5)

34 (9.2)

0.23

Stage 2

55 (4.5)

37 (10.0)

<0.001

Day 0 KDIGO AKI

Author Manuscript

Stage 3

Author Manuscript

23 (1.9)

49 (13.3)

<0.001

218 (17.8)

120 (32.6)

<0.001

Severe AKI

78 (6.4)

86 (23.4)

<0.001

Ventricular Assist Device

3 (0.2)

1 (0.3)

0.93

ECMO

14 (1.1)

9 (2.4)

0.07

Renal Replacement Therapy

18 (1.5)

40 (10.9)

<0.001

MV Duration

1 (0, 6)

1 (0, 5)

0.57

ICU LOS

5 (4, 9)

4 (3, 7.8)

<0.001

Mortality

53 (4.3)

28 (7.6)

0.01

All-stage AKI

Categorical Variables expressed as n (% of cohort)
Continuous Variables expressed as medians with interquartile ranges
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Day 3 AKI = KDIGO ≥ Stage 2

*

More than one diagnosis group is possible

Author Manuscript

N = population, BSA = body surface area, IQR = interquartile range, CV = cardiovascular, CNS = central nervous system, PRISM-3 = Pediatric
Risk of Mortality 3, PIM-2 =Pediatric Index of Mortality 2, PELOD = Pediatric Logistic Organ Dysfunction, KDIGO - Kidney Diseases Improving
Global Outcomes, AKI = acute kidney injury, RA+ = renal angina positive, ICU = intensive care unit, ECMO = extracorporeal membrane
oxygenation, MV = mechanical ventilation, LOS = length of stay
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Table 3

Author Manuscript

Creatinine Elevation versus Renal Angina Fulfillment
SCr>Base
N = 696 (43.8)

RA+
N = 286 (17.9)

P value

386 (55.4)

144 (50.3)

0.14

45.6 (11.4, 143.8)

49.9 (11.5,155.0)

0.43

226 (32.5)

135 (47.2)

<0.001

46 (6.6)

20 (6.9)

0.82

Trauma

133 (19.1)

64 (22.4)

0.25

CNS

134 (19.3)

39 (13.6)

0.04

5 (3,9)

7(2,14)

0.09

Variable
Male
Age in months
Primary Diagnosis Group*
Shock
CV

Author Manuscript

Severity of Illness Score
PRISM-3

Author Manuscript

PIM-2

2.5 (1,5)

3 (1,6)

0.16

PELOD

11 (1,12)

11 (1,19)

0.13

History of Transplantation

81 (11.6)

57 (19.9)

<0.001

No AKI

404 (58.0)

121 (42.3)

<0.001

Stage 1

109 (15.7)

44 (15.4)

0.91

Stage 2

61 (8.7)

41 (14.3)

0.009

Stage 3

122 (17.5)

80 (27.9)

<0.001

All-stage AKI (AKIA)

292 (41.9)

165 (57.7)

<0.001

Severe AKI (AKIS)

184 (26.4)

121 (42.3)

<0.001

1.61 (1.33–1.93)

<0.001

Day 3 AKI Incidence

Relative Risk (AKIS)#
AKIS Prediction
Sensitivity

80 (56–94)

67 (59–75)

Specificity

70 (62–77)

87 (85–88)

Positive Predictive Value

25 (20–32)

31(28–35)

Negative Predictive Value

96 (92–99)

97 (96–97)

Positive Likelihood Ratio

2.6 (1.9–3.6)

5.0 (4.2–5.9)

0.86 (0.82–0.89)

0.83 (0.79–0.86)

RRT Use

41 (5.9)

36 (12.6)

<0.001

MV Duration

1 (0,6)

3.5 (0,9)

<0.001

ECMO

14 (2.0)

9 (3.8)

0.29

ICU LOS

5 (3,9)

5 (3,10)

0.96

Mortality

44 (6.3)

32 (11.2)

0.009

AUC-ROC

Author Manuscript
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Categorical Variables expressed as n (% of cohort)
Continuous Variables expressed as medians with interquartile ranges

*

More than one diagnosis group is possible

Author Manuscript

#

Z-statistic: 5.07

SCr>Base = Serum creatinine greater than baseline creatinine, RA+ = renal angina fulfillment, AKI = acute kidney injury, BSA = body surface
area, CV = cardiovascular, CNS = central nervous system, PRISM-III = Pediatric Risk of Mortality Score III, PIM-2 = Pediatric Index of
Mortality-2, PELOD = Pediatric Logistic Organ Dysfunction, AUC-ROC = area under curve receiver operating characteristic, MV duration =
mechanical ventilation duration, ICU = intensive care unit, ECMO = extracorporeal membrane oxygenation, RRT=Renal replacement therapy, LOS
= length of stay

Author Manuscript
Author Manuscript
Author Manuscript
Lancet Child Adolesc Health. Author manuscript; available in PMC 2019 February 01.

Basu et al.

Page 21

Table 4

Author Manuscript

Multivariable Logistic Regression Comparison for AKIS Prediction
Odds Ratio of Either Renal Angina+ or SCr>Base for Day3-AKIS
Model Terms
Age ≥ 75 months
BSA ≥ 0.84

m2

RA+

SCr>Base

1.28 (0.73–2.23)

1.37 (0.79–2.37)

1.11 (0.63–1.94)

1.02 (0.58–1.76)

Author Manuscript

Shock Dx

1.21 (0.88–1.67)

1.39 (1.02–1.90)

Cardiovascular Dx

0.95 (0.53–1.68)

0.98 (0.56–1.73)

Trauma Dx

1.29 (0.93–1.82)

1.29 (0.93–1.79)

Absence of CNS Dx

0.96 (0.67–1.36)

0.99 (0.70–1.40)

Transplant History

1.87 (1.15–3.03)

2.49 (1.56–3.97)

Renal Angina

2.61 (1.88–3.63)

n/a

SCr>Base

n/a

1.02 (0.78–1.35)

Model Terms

Inclusion of both Renal Angina+ and SCr>Base into Regression Model

Age ≥ 75 months

1.25 (0.71–2.19)

BSA ≥ 0.84 m2

1.12 (0.64–1.97)

Shock Dx

1.20 (0.64–1.97)

Cardiovascular Dx

0.94 (0.53–1.67)

Trauma Dx

1.27 (0.91–1.78)

Absence of CNS Dx

0.95 (0.67–1.35)

Transplant History

1.97 (1.21–3.20)

SCr>Base

0.68 (0.49–0.94)

Renal Angina

3.21 (2.20–4.67)

Author Manuscript

N=368 patients
Results are expressed as odds ratios with 95% confidence intervals
AKI = acute kidney injury, CI = confidence interval, Dx = diagnosis, RA+=renal angina positive, SCr>Base = serum creatinine greater than
baseline, BSA = body surface area, CNS = central nervous system
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Table 5
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Multivariable Logistic Regression for Prediction of Secondary Outcomes Renal Replacement Therapy
Utilization#
Odds Ratio of Either Renal Angina+ or SCr>Base for AKIS
Model Terms

Author Manuscript

RA+

SCr>Base

2.03 (0.61–6.69)

2.47 (0.78–7.77)

0.50 (0.15–1.69)

0.40 (0.13–1.31)

Shock Dx

2.52 (1.24–5.13)

3.02 (1.52–6.03)

Cardiovascular Dx

1.25 (0.36–4.34)

1.26 (0.37–4.32)

Absence of Trauma Dx

2.56 (0.83–7.89)

2.45 (0.80–7.47)

Absence of CNS Dx

1.16 (0.46–2.90)

1.19 (0.48–2.97)

Transplant Hx

3.32 (1.34–8.19)

4.22 (1.75–10.15)

Renal Angina

4.12 (2.08–8.17)

n/a

SCr>Base

n/a

1.92 (0.97–3.82)

Age > 83 months
BSA > 0.87

m2

Author Manuscript

Model Terms

Inclusion of both Renal Angina+ and SCr>Base into Regression Model

Age > 83 months

2.03 (0.61–6.68)

BSA > 0.87 m2

0.50 (0.15–1.69)

Shock Dx

2.52 (1.24–5.13)

Cardiovascular Dx

1.25 (0.36–4.34)

Absence of Trauma Dx

2.56 (0.83–7.89)

Absence of CNS Dx

1.16 (0.46–2.90)

Transplant Hx

3.30 (1.33–8.21)

SCr>Base

1.02 (0.46–2.31)

Renal Angina

4.07 (1.83–9.04)

Mortality^
Exclusion of Either Renal Angina+ or SCr>Base from Regression Model
Model Terms
RA+

SCr>Base

Shock Dx

1.12 (0.66–1.89)

1.29 (0.78–2.15)

Cardiovascular Dx

2.59 (1.25–5.42)

2.64 (1.27–5.47)

Absence of Trauma Dx

2.09 (0.91–4.78)

2.02 (0.88–4.61)

CNS Dx

2.53 (1.48–4.31)

2.42 (1.43–4.11)

Transplant History

1.32 (0.59–2.95)

1.52 (0.69–3.37)

Renal Angina

2.38 (1.36–4.15)

n/a

Author Manuscript

SCr>Base

n/a

1.22 (0.75–1.99)

All-stage AKI

0.99 (0.59–1.68)

1.15

ECMO

2.56 (0.80–8.16)

2.55 (0.81–8.06)

RRT Use

6.05 (2.89–12.63)

7.48 (3.65–15.31)

Inclusion of both Renal Angina+ and SCr>Base into Regression Model
Model Terms
Odds Ratio

95% CI
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Odds Ratio of Either Renal Angina+ or SCr>Base for AKIS
Model Terms

Author Manuscript

RA+

SCr>Base

Shock Dx

1.16

0.66–1.88

Cardiovascular Dx

2.59

1.24–5.43

Absence of Trauma Dx

2.11

0.92–4.83

CNS Dx

2.52

1.48–4.30

Transplant Hx

1.34

0.60–2.99

SCr>Base

0.86

0.49–1.51

Renal Angina

2.58

1.36–4.89

All stage AKI

1.01

0.60–1.71

ECMO

2.59

0.81–8.23

RRT Use

6.04

2.89–12.59

#

Author Manuscript

58 patients,

^

81 patients

Model terms included demonstrated bivariate association with outcome p ≤ 0.15
BSA = body surface area, Dx = diagnosis, Hx = history, CNS = central nervous system, SCr>Base = Serum creatinine greater than baseline
creatinine, RA+ = renal angina fulfillment, AKI = acute kidney injury, ICU = intensive care unit, ECMO = extracorporeal membrane oxygenation,
RRT=Renal replacement therapy
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